Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Annals of Behavioral Medicine
Erschienen in: Annals of Behavioral Medicine 1/2012

01.08.2012 | Original Article

Behavioral Medicine Approaches to Chronic Obstructive Pulmonary Disease

verfasst von: Andreas von Leupoldt, Ph.D., Anja Fritzsche, Ph.D., Ana F. Trueba, M.A., Alicia E. Meuret, Ph.D., Thomas Ritz, Ph.D.

Erschienen in: Annals of Behavioral Medicine | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory disease and associated with considerable individual and socioeconomic burden. Recent research started examining the role of psychosocial factors for course and management of the disease.

Purpose

This review provides an overview on recent findings on psychosocial factors and behavioral medicine approaches in COPD.

Results

Research has identified several important psychosocial factors and effective behavioral medicine interventions in COPD. However, there is considerable need for future research in this field.

Conclusions

Although beneficial effects of some behavioral medicine interventions have been demonstrated in COPD, future research efforts are necessary to study the effects of distinct components of these interventions, to thoroughly examine promising but yet not sufficiently proven interventions, and to develop new creative interventions.
Literatur
1.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD. 2010; Available from: http://​www.​goldcopd.​com.
2.
Gershon AS, Warner L, Cascagnette P, Victor JC, To T. Lifetime risk of developing chronic obstructive pulmonary disease: A longitudinal population study. Lancet. 2011 Sep 10;378(9795):991–6.PubMedCrossRef
3.
Kaptein AA, Scharloo M, Fischer MJ, Snoei L, Hughes BM, Weinman J, et al. 50 years of psychological research on patients with COPD—road to ruin or highway to heaven? Respir Med. 2009 Jan;103(1):3–11.PubMedCrossRef
4.
National Clinical Guideline Centre. Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care. 2010; Available from: http://​www.​nice.​org.​uk/​CG101.
5.
O’Donnell DE, Banzett RB, Carrieri-Kohlman V, Casaburi R, Davenport PW, Gandevia SC, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: A roundtable. Proc Am Thorac Soc. 2007 Mai;4(2):145–68.PubMedCrossRef
6.
American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: A consensus statement. Am. J. Respir. Crit. Care Med. 1999 Jan;159(1):321–40.
7.
Carrieri-Kohlman V, Gormley JM, Eiser S, Demir-Deviren S, Nguyen H, Paul SM, et al. Dyspnea and the affective response during exercise training in obstructive pulmonary disease. Nurs Res. 2001 Juni;50(3):136–46.PubMedCrossRef
8.
Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: Review and hypotheses. Respir Physiol Neurobiol. 2009 Mai 30;167(1):53–60.PubMedCrossRef
9.
Meek PM, Lareau SC, Hu J. Are self-reports of breathing effort and breathing distress stable and valid measures among persons with asthma, persons with COPD, and healthy persons? Heart Lung. 2003 Okt;32(5):335–46.PubMedCrossRef
10.
von Leupoldt A, Dahme B. Differentiation between the sensory and affective dimension of dyspnea during resistive load breathing in normal subjects. Chest. 2005 Nov;128(5):3345–9.CrossRef
11.
Davenport PW, Vovk A. Cortical and subcortical central neural pathways in respiratory sensations. Respir Physiol Neurobiol. 2009 Mai 30;167(1):72–86.PubMedCrossRef
12.
Evans KC. Cortico-limbic circuitry and the airways: Insights from functional neuroimaging of respiratory afferents and efferents. Biol Psychol. 2010 Apr;84(1):13–25.PubMedCrossRef
13.
von Leupoldt A, Dahme B. Cortical substrates for the perception of dyspnea. Chest. 2005 Juli;128(1):345–54.CrossRef
14.
von Leupoldt A, Sommer T, Kegat S, Baumann HJ, Klose H, Dahme B, et al. The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala. Am. J. Respir. Crit. Care Med. 2008 Mai 1;177(9):1026–32.CrossRef
15.
von Leupoldt A, Sommer T, Kegat S, Eippert F, Baumann HJ, Klose H, et al. Down-regulation of insular cortex responses to dyspnea and pain in asthma. Am. J. Respir. Crit. Care Med. 2009 Aug 1;180(3):232–8.CrossRef
16.
Schön D, Rosenkranz M, Regelsberger J, Dahme B, Büchel C, von Leupoldt A. Reduced perception of dyspnea and pain after right insular cortex lesions. Am. J. Respir. Crit. Care Med. 2008 Dez 1;178(11):1173–9.PubMedCrossRef
17.
Peiffer C. Dyspnea and emotion: What can we learn from functional brain imaging? Am. J. Respir. Crit. Care Med. 2008 Mai 1;177(9):937–9.PubMedCrossRef
18.
von Leupoldt A, Taube K, Henkhus M, Dahme B, Magnussen H. The impact of affective states on the perception of dyspnea in patients with chronic obstructive pulmonary disease. Biol Psychol. 2010 Apr;84(1):129–34.CrossRef
19.
von Leupoldt A, Taube K, Schubert-Heukeshoven S, Magnussen H, Dahme B. Distractive auditory stimuli reduce the unpleasantness of dyspnea during exercise in patients with COPD. Chest. 2007 Nov;132(5):1506–12.CrossRef
20.
Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 2009 Mai;33(5):1165–85.PubMedCrossRef
21.
Chen JC, Mannino DM. Worldwide epidemiology of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 1999 März;5(2):93–9.PubMedCrossRef
22.
Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, et al. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet. 2007 Sep 1;370(9589):741–50.PubMedCrossRef
23.
Menezes AMB, Perez-Padilla R, Jardim JRB, Muiño A, Lopez MV, Valdivia G, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): A prevalence study. Lancet. 2005 Nov 26;366(9500):1875–81.PubMedCrossRef
24.
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006 Nov;3(11):e442.PubMedCrossRef
25.
26.
O’Donnell DE, Hernandez P, Kaplan A, Aaron S, Bourbeau J, Marciniuk D, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2008 update—highlights for primary care. Can. Respir. J. 2008 Feb;15 Suppl A:1A–8A.
27.
Wedzicha JA, Seemungal TAR. COPD exacerbations: Defining their cause and prevention. Lancet. 2007 Sep 1;370(9589):786–96.PubMedCrossRef
28.
Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: Results from the TORCH study. Am. J. Respir. Crit. Care Med. 2008 Aug 15;178(4):332–8.PubMedCrossRef
29.
Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): A prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009 Okt 3;374(9696):1171–8.PubMedCrossRef
30.
Vogelmeier C, Buhl R, Criée CP, Gillissen A, Kardos P, Köhler D, et al. Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin. Pneumologie. 2007 Mai;61(5):e1–40.PubMedCrossRef
31.
Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs. Chest. 2008 Okt;134(4 Suppl):43S–56S.PubMedCrossRef
32.
Kullowatz A, Kanniess F, Dahme B, Magnussen H, Ritz T. Association of depression and anxiety with health care use and quality of life in asthma patients. Respir Med. 2007 März;101(3):638–44.PubMedCrossRef
33.
Sandberg S, Järvenpää S, Penttinen A, Paton JY, McCann DC. Asthma exacerbations in children immediately following stressful life events: a Cox’s hierarchical regression. Thorax. 2004 Dez;59(12):1046–51.PubMedCrossRef
34.
Wright RJ. Perinatal stress and early life programming of lung structure and function. Biol Psychol. 2010 Apr;84(1):46–56.PubMedCrossRef
35.
Kullowatz A, Rosenfield D, Dahme B, Magnussen H, Kanniess F, Ritz T. Stress effects on lung function in asthma are mediated by changes in airway inflammation. Psychosom Med. 2008 Mai;70(4):468–75.PubMedCrossRef
36.
Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: Prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010 Dez;25(12):1209–21.PubMedCrossRef
37.
Yohannes AM, Baldwin RC, Connolly MJ. Mood disorders in elderly patients with chronic obstructive pulmonary disease. Reviews in Clinical Gerontology. 2000;10(02):193–202.CrossRef
38.
de Voogd JN, Wempe JB, Koëter GH, Postema K, van Sonderen E, Ranchor AV, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest. 2009 März;135(3):619–25.PubMedCrossRef
39.
Eisner MD, Blanc PD, Yelin EH, Katz PP, Sanchez G, Iribarren C, et al. Influence of anxiety on health outcomes in COPD. Thorax. 2010 März;65(3):229–34.PubMedCrossRef
40.
Giardino ND, Curtis JL, Andrei A-C, Fan VS, Benditt JO, Lyubkin M, et al. Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: A cross-sectional study. Respir. Res. 2010;11:29.PubMedCrossRef
41.
Laurin C, Labrecque M, Dupuis G, Bacon SL, Cartier A, Lavoie KL. Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations. Psychosom Med. 2009 Juli;71(6):667–74.PubMedCrossRef
42.
Ng T-P, Niti M, Tan W-C, Cao Z, Ong K-C, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: Effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch. Intern. Med. 2007 Jan 8;167(1):60–7.PubMedCrossRef
43.
Vögele C, von Leupoldt A. Mental disorders in chronic obstructive pulmonary disease (COPD). Respir Med. 2008 Mai;102(5):764–73.PubMedCrossRef
44.
von Leupoldt A, Taube K, Lehmann K, Fritzsche A, Magnussen H. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest. 2011 Sep;140(3):730–6.CrossRef
45.
Xu W, Collet J-P, Shapiro S, Lin Y, Yang T, Platt RW, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am. J. Respir. Crit. Care Med. 2008 Nov 1;178(9):913–20.PubMedCrossRef
46.
Quint JK, Baghai-Ravary R, Donaldson GC, Wedzicha JA. Relationship between depression and exacerbations in COPD. Eur. Respir. J. 2008 Juli;32(1):53–60.PubMedCrossRef
47.
Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, et al. Functional impairment in COPD patients: The impact of anxiety and depression. Psychosomatics. 2000 Dez;41(6):465–71.PubMedCrossRef
48.
Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005 Apr;127(4):1205–11.PubMedCrossRef
49.
Neuman A, Gunnbjörnsdottir M, Tunsäter A, Nyström L, Franklin KA, Norrman E, et al. Dyspnea in relation to symptoms of anxiety and depression: A prospective population study. Respir Med. 2006 Okt;100(10):1843–9.PubMedCrossRef
50.
Livermore N, Sharpe L, McKenzie D. Panic attacks and panic disorder in chronic obstructive pulmonary disease: A cognitive behavioral perspective. Respir Med. 2010 Sep;104(9):1246–53.PubMedCrossRef
51.
Al-shair K, Kolsum U, Dockry R, Morris J, Singh D, Vestbo J. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir. Res. 2011;12:3.PubMedCrossRef
52.
Spruit MA, Watkins ML, Edwards LD, Vestbo J, Calverley PMA, Pinto-Plata V, et al. Determinants of poor 6-min walking distance in patients with COPD: The ECLIPSE cohort. Respir Med. 2010 Juni;104(6):849–57.PubMedCrossRef
53.
54.
Kaplan RM, Ries AL. Chronic obstructive pulmonary disease: Behavioural assessment and treatment. In: A. A.Kaptein, T. L.Creer (eds.) Respiratory Disorders and Behavioral Medicine. London: Martin Dunitz; 2002. p. 85–116.
55.
Grodner S, Prewitt LM, Jaworsk BA, Myers R, Kaplan RM, Ries AL. The impact of social support in pulmonary rehabilitation of patients with chronic obstructive pulmonary disease. Annals of Behavioral Medicine. 1996 Sep;18:139–45.CrossRef
56.
Wong AWM, Gan WQ, Burns J, Sin DD, van Eeden SF. Acute exacerbation of chronic obstructive pulmonary disease: Influence of social factors in determining length of hospital stay and readmission rates. Can. Respir. J. 2008 Okt;15(7):361–4.PubMed
57.
Haave E, Hyland M. Different short-term and longitudinal results on perceived health status for asthma and COPD patients after pulmonary rehabilitation. Patients living alone have the largest improvements in perceived quality of life. Chron Respir Dis. 2008;5(2):69–73.PubMedCrossRef
58.
Trappenburg JC, Troosters T, Spruit MA, Vandebrouck N, Decramer M, Gosselink R. Psychosocial conditions do not affect short-term outcome of multidisciplinary rehabilitation in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2005 Sep;86(9):1788–92.PubMedCrossRef
59.
Kara Kaşikçi M, Alberto J. Family support, perceived self-efficacy and self-care behaviour of Turkish patients with chronic obstructive pulmonary disease. J Clin Nurs. 2007 Aug;16(8):1468–78.PubMedCrossRef
60.
61.
Kühl K, Schürmann W, Rief W. Mental disorders and quality of life in COPD patients and their spouses. Int J Chron Obstruct Pulmon Dis. 2008;3(4):727–36.PubMed
62.
Pinto RA, Holanda MA, Medeiros MMC, Mota RMS, Pereira EDB. Assessment of the burden of caregiving for patients with chronic obstructive pulmonary disease. Respir Med. 2007 Nov;101(11):2402–8.PubMedCrossRef
63.
Tønnesen P, Carrozzi L, Fagerström KO, Gratziou C, Jimenez-Ruiz C, Nardini S, et al. Smoking cessation in patients with respiratory diseases: A high priority, integral component of therapy. Eur. Respir. J. 2007 Feb;29(2):390–417.PubMedCrossRef
64.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606–13.PubMedCrossRef
65.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Juni;67(6):361–70.PubMedCrossRef
66.
Jones PW, Price D, van der Molen T. Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:289–96.PubMedCrossRef
67.
ZuWallack RL, Haggerty MC, Jones P. Clinically meaningful outcomes in patients with chronic obstructive pulmonary disease. Am. J. Med. 2004 Dez 20;117 Suppl 12A:49S-59S.PubMed
68.
Lareau SC, Yawn BP. Improving adherence with inhaler therapy in COPD. Int J Chron Obstruct Pulmon Dis. 2010;5:401–6.PubMedCrossRef
69.
Vestbo J, Anderson JA, Calverley PMA, Celli B, Ferguson GT, Jenkins C, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009 Nov;64(11):939–43.PubMedCrossRef
70.
Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2006 Juni 15;173(12):1390–413.PubMedCrossRef
71.
Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;(4):CD003793.
72.
Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, et al. Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007 Mai;131(5 Suppl):4S-42S.PubMedCrossRef
73.
Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;(10):CD005305.
74.
Beauchamp MK, Janaudis-Ferreira T, Goldstein RS, Brooks D. Optimal duration of pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease—a systematic review. Chron Respir Dis. 2011;8(2):129–40.PubMed
75.
Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005 März;127(3):809–17.PubMedCrossRef
76.
Waschki B, Kirsten A, Holz O, Müller K-C, Meyer T, Watz H, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: A prospective cohort study. Chest. 2011 Aug;140(2):331–42.PubMedCrossRef
77.
Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial. Lancet. 2000 Jan 29;355(9201):362–8.PubMedCrossRef
78.
Behnke M, Jörres RA, Kirsten D, Magnussen H. Clinical benefits of a combined hospital and home-based exercise programme over 18 months in patients with severe COPD. Monaldi Arch Chest Dis. 2003 März;59(1):44–51.PubMed
79.
du Moulin M, Taube K, Wegscheider K, Behnke M, van den Bussche H. Home-based exercise training as maintenance after outpatient pulmonary rehabilitation. Respiration. 2009;77(2):139–45.PubMedCrossRef
80.
Maltais F, Bourbeau J, Shapiro S, Lacasse Y, Perrault H, Baltzan M, et al. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: A randomized trial. Ann. Intern. Med. 2008 Dez 16;149(12):869–78.PubMed
81.
Harris M, Smith BJ, Veale A. Patient education programs—can they improve outcomes in COPD? Int J Chron Obstruct Pulmon Dis. 2008;3(1):109–12.PubMed
82.
Kaptein AA, Scharloo M, Fischer MJ, Snoei L, Cameron LD, Sont JK, et al. Illness perceptions and COPD: An emerging field for COPD patient management. J Asthma. 2008 Okt;45(8):625–9.PubMedCrossRef
83.
Effing T, Monninkhof EM, van der Valk PDLPM, van der Palen J, van Herwaarden CLA, Partidge MR, et al. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2007;(4):CD002990.
84.
Peytremann-Bridevaux I, Staeger P, Bridevaux P-O, Ghali WA, Burnand B. Effectiveness of chronic obstructive pulmonary disease-management programs: Systematic review and meta-analysis. Am. J. Med. 2008 Mai;121(5):433–43.e4.PubMedCrossRef
85.
Nguyen HQ, Carrieri-Kohlman V, Rankin SH, Slaughter R, Stulbarg MS. Is Internet-based support for dyspnea self-management in patients with chronic obstructive pulmonary disease possible? Results of a pilot study. Heart Lung. 2005 Feb;34(1):51–62.PubMedCrossRef
86.
Nguyen HQ, Donesky-Cuenco D, Wolpin S, Reinke LF, Benditt JO, Paul SM, et al. Randomized controlled trial of an internet-based versus face-to-face dyspnea self-management program for patients with chronic obstructive pulmonary disease: Pilot study. J. Med. Internet Res. 2008;10(2):e9.PubMedCrossRef
87.
Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007 Feb 22;356(8):775–89.PubMedCrossRef
88.
Andreas S, Hering T, Mühlig S, Nowak D, Raupach T, Worth H. Smoking cessation in chronic obstructive pulmonary disease: An effective medical intervention. Dtsch Arztebl Int. 2009 Apr;106(16):276–82.PubMed
89.
Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA. 1994 Nov 16;272(19):1497–505.PubMedCrossRef
90.
Kanner RE, Connett JE, Williams DE, Buist AS. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: The Lung Health Study. Am. J. Med. 1999 Apr;106(4):410–6.PubMedCrossRef
91.
Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am. J. Respir. Crit. Care Med. 2000 Feb;161(2 Pt 1):381–90.PubMed
92.
Rigotti NA, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2007;(3):CD001837.
93.
Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005;(2):CD001007.
94.
van der Meer RM, Wagena EJ, Ostelo RWJG, Jacobs JE, van Schayck CP. Smoking cessation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2003;(2):CD002999.
95.
Gosselink R, De Vos J, van den Heuvel SP, Segers J, Decramer M, Kwakkel G. Impact of inspiratory muscle training in patients with COPD: What is the evidence? Eur. Respir. J. 2011 Feb;37(2):416–25.PubMedCrossRef
96.
Lötters F, van Tol B, Kwakkel G, Gosselink R. Effects of controlled inspiratory muscle training in patients with COPD: A meta-analysis. Eur. Respir. J. 2002 Sep;20(3):570–6.PubMedCrossRef
97.
Bausewein C, Booth S, Gysels M, Higginson I. Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. 2008;(2):CD005623.
98.
Gosselink R. Controlled breathing and dyspnea in patients with chronic obstructive pulmonary disease (COPD). J Rehabil Res Dev. 2003 Okt;40(5 Suppl 2):25–33.PubMedCrossRef
99.
Marciniuk D, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, et al. Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: A Canadian Thoracic Society clinical practice guideline. Can. Respir. J. 2011 Apr;18(2):69–78.PubMed
100.
Bianchi R, Gigliotti F, Romagnoli I, Lanini B, Castellani C, Grazzini M, et al. Chest wall kinematics and breathlessness during pursed-lip breathing in patients with COPD. Chest. 2004 Feb;125(2):459–65.PubMedCrossRef
101.
Nield MA, Soo Hoo GW, Roper JM, Santiago S. Efficacy of pursed-lips breathing: A breathing pattern retraining strategy for dyspnea reduction. J Cardiopulm Rehabil Prev. 2007 Aug;27(4):237–44.PubMed
102.
Gigliotti F, Romagnoli I, Scano G. Breathing retraining and exercise conditioning in patients with chronic obstructive pulmonary disease (COPD): A physiological approach. Respir Med. 2003 März;97(3):197–204.PubMedCrossRef
103.
Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG. Nutritional status and mortality in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1996 März;153(3):961–6.PubMed
104.
Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am. Rev. Respir. Dis. 1989 Juni;139(6):1435–8.PubMed
105.
King DA, Cordova F, Scharf SM. Nutritional aspects of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008 Mai 1;5(4):519–23.PubMedCrossRef
106.
Fritzsche A, Clamor A, von Leupoldt A. Effects of medical and psychological treatment of depression in patients with COPD—a review. Respir Med. 2011 Okt;105(10):1422–33.PubMedCrossRef
107.
Brenes GA. Anxiety and chronic obstructive pulmonary disease: Prevalence, impact, and treatment. Psychosom Med. 2003 Dez;65(6):963–70.PubMedCrossRef
108.
Butler AC, Beck A. Cognitive therapy for depression. The Clinical Psychologist. 1995;48(3):3–5.
109.
Ingram RE. The International Encyclopedia of Depression. New York: Springer; 2009.
110.
Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol. 1998 Mai;17(3):232–40.PubMedCrossRef
111.
Kunik ME, Braun U, Stanley MA, Wristers K, Molinari V, Stoebner D, et al. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med. 2001 Mai;31(4):717–23.PubMedCrossRef
112.
Kunik ME, Veazey C, Cully JA, Souchek J, Graham DP, Hopko D, et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: A randomized controlled trial. Psychol Med. 2008 März;38(3):385–96.PubMedCrossRef
113.
Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: A review of meta-analyses. Clin Psychol Rev. 2006 Jan;26(1):17–31.PubMedCrossRef
114.
Mitte K. A meta-analysis of the efficacy of psycho- and pharmacotherapy in panic disorder with and without agoraphobia. J Affect Disord. 2005 Sep;88(1):27–45.PubMedCrossRef
115.
Stewart RE, Chambless DL. Cognitive-behavioral therapy for adult anxiety disorders in clinical practice: A meta-analysis of effectiveness studies. J Consult Clin Psychol. 2009 Aug;77(4):595–606.PubMedCrossRef
116.
Baraniak A, Sheffield D. The efficacy of psychologically based interventions to improve anxiety, depression and quality of life in COPD: A systematic review and meta-analysis. Patient Educ Couns. 2011 Apr;83(1):29–36.PubMedCrossRef
117.
Hynninen MJ, Bjerke N, Pallesen S, Bakke PS, Nordhus IH. A randomized controlled trial of cognitive behavioral therapy for anxiety and depression in COPD. Respir Med. 2010 Juli;104(7):986–94.PubMedCrossRef
118.
Livermore N, Sharpe L, McKenzie D. Prevention of panic attacks and panic disorder in COPD. Eur. Respir. J. 2010 März;35(3):557–63.PubMedCrossRef
119.
Lehrer PM, Hochron SM, Mayne TM, Isenberg S, Lasoski AM, Carlson V, et al. Relationship between changes in EMG and respiratory sinus arrhythmia in a study of relaxation therapy for asthma. Appl Psychophysiol Biofeedback. 1997 Sep;22(3):183–91.PubMedCrossRef
120.
Ritz T. Relaxation therapy in adult asthma. Is there new evidence for its effectiveness? Behav Modif. 2001 Sep;25(4):640–66.PubMedCrossRef
121.
Jorm AF, Morgan AJ, Hetrick SE. Relaxation for depression. Cochrane Database Syst Rev. 2008;(4):CD007142.
122.
Lehrer PM, Woolfolk RL, Sime WE. Principles and Practice of Stress Management, Third Edition. Third Edition. New York: Guilford; 2007.
123.
Donesky-Cuenco D, Nguyen HQ, Paul S, Carrieri-Kohlman V. Yoga therapy decreases dyspnea-related distress and improves functional performance in people with chronic obstructive pulmonary disease: A pilot study. J Altern Complement Med. 2009 März;15(3):225–34.PubMedCrossRef
124.
Estève F, Blanc-Gras N, Gallego J, Benchetrit G. The effects of breathing pattern training on ventilatory function in patients with COPD. Biofeedback Self Regul. 1996 Dez;21(4):311–21.PubMedCrossRef
125.
Reybrouck T, Wertelaers A, Bertrand P, Demedts M. Myofeedback training of the respiratory muscles in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 1987;7:18–22.
126.
Tiep BL, Burns M, Kao D, Madison R, Herrera J. Pursed lips breathing training using ear oximetry. Chest. 1986 Aug;90(2):218–21.PubMedCrossRef
127.
Giardino ND, Chan L, Borson S. Combined heart rate variability and pulse oximetry biofeedback for chronic obstructive pulmonary disease: Preliminary findings. Appl Psychophysiol Biofeedback. 2004 Juni;29(2):121–33.PubMedCrossRef
128.
Vaschillo E, Vaschillo B, Lehrer P. Heartbeat synchronizes with respiratory rhythm only under specific circumstances. Chest. 2004 Okt;126(4):1385–6.PubMedCrossRef
129.
Yasuma F, Hayano J-I. Respiratory sinus arrhythmia: Why does the heartbeat synchronize with respiratory rhythm? Chest. 2004 Feb;125(2):683–90.PubMedCrossRef
130.
Collins EG, Fehr L, Bammert C, O’Connell S, Laghi F, Hanson K, et al. Effect of ventilation-feedback training on endurance and perceived breathlessness during constant work-rate leg-cycle exercise in patients with COPD. J Rehabil Res Dev. 2003 Okt;40(5 Suppl 2):35–44.PubMedCrossRef
131.
Collins EG, Langbein WE, Fehr L, O’Connell S, Jelinek C, Hagarty E, et al. Can ventilation-feedback training augment exercise tolerance in patients with chronic obstructive pulmonary disease? Am. J. Respir. Crit. Care Med. 2008 Apr 15;177(8):844–52.PubMedCrossRef
132.
von Leupoldt A, Dahme B. Psychological aspects in the perception of dyspnea in obstructive pulmonary diseases. Respir Med. 2007 März;101(3):411–22.CrossRef
133.
von Leupoldt A, Seemann N, Gugleva T, Dahme B. Attentional distraction reduces the affective but not the sensory dimension of perceived dyspnea. Respir Med. 2007 Apr;101(4):839–44.CrossRef
134.
Davenport PW, Chan P-YS, Zhang W, Chou Y-L. Detection threshold for inspiratory resistive loads and respiratory-related evoked potentials. J. Appl. Physiol. 2007 Jan;102(1):276–85.PubMedCrossRef
135.
Webster KE, Colrain IM. The respiratory-related evoked potential: Effects of attention and occlusion duration. Psychophysiology. 2000 Mai;37(3):310–8.PubMedCrossRef
136.
Bauldoff GS, Hoffman LA, Zullo TG, Sciurba FC. Exercise maintenance following pulmonary rehabilitation: Effect of distractive stimuli. Chest. 2002 Sep;122(3):948–54.PubMedCrossRef
137.
Thornby MA, Haas F, Axen K. Effect of distractive auditory stimuli on exercise tolerance in patients with COPD. Chest. 1995 Mai;107(5):1213–7.PubMedCrossRef
138.
Bauldoff GS, Rittinger M, Nelson T, Doehrel J, Diaz PT. Feasibility of distractive auditory stimuli on upper extremity training in persons with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2005 Feb;25(1):50–5.PubMedCrossRef
139.
Brooks D, Sidani S, Graydon J, McBride S, Hall L, Weinacht K. Evaluating the effects of music on dyspnea during exercise in individuals with chronic obstructive pulmonary disease: A pilot study. Rehabil Nurs. 2003 Dez;28(6):192–6.PubMed
140.
Pfister T, Berrol C, Caplan C. Effects of music on exercise and perceived symptoms in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 1998 Juni;18(3):228–32.PubMedCrossRef
141.
Brutsche MH, Grossman P, Müller RE, Wiegand J, Pello, Baty F, et al. Impact of laughter on air trapping in severe chronic obstructive lung disease. Int J Chron Obstruct Pulmon Dis. 2008;3(1):185–92.PubMed
142.
Lebowitz KR, Suh S, Diaz PT, Emery CF. Effects of humor and laughter on psychological functioning, quality of life, health status, and pulmonary functioning among patients with chronic obstructive pulmonary disease: A preliminary investigation. Heart Lung. 2011 Aug;40(4):310–9.PubMedCrossRef
143.
Bonilha AG, Onofre F, Vieira ML, Prado MYA, Martinez JAB. Effects of singing classes on pulmonary function and quality of life of COPD patients. Int J Chron Obstruct Pulmon Dis. 2009;4:1–8.PubMed
144.
Lord VM, Cave P, Hume VJ, Flude EJ, Evans A, Kelly JL, et al. Singing teaching as a therapy for chronic respiratory disease—a randomised controlled trial and qualitative evaluation. BMC Pulm Med. 2010;10:41.PubMedCrossRef
Metadaten
Titel
Behavioral Medicine Approaches to Chronic Obstructive Pulmonary Disease
verfasst von
Andreas von Leupoldt, Ph.D.
Anja Fritzsche, Ph.D.
Ana F. Trueba, M.A.
Alicia E. Meuret, Ph.D.
Thomas Ritz, Ph.D.
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Annals of Behavioral Medicine / Ausgabe 1/2012
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-012-9348-7

Weitere Artikel der Ausgabe 1/2012

Annals of Behavioral Medicine 1/2012 Zur Ausgabe

Original Article

The Influence of Informal Caregivers on Adherence in COPD Patients

Invited Commentary

If God is in Control of my Health, What Should I Do? The Importance of Religious, Ethnic, and Social Culture: a Comment on Umezawa et al.

Original Article

Predictors of Leisure Time Physical Activity Among People with Spinal Cord Injury

Invited Commentary

Circadian Disruption—a New Direction for Psycho-oncology Research? A Comment on Dedert et al.

Original Article

Avoidance of Activities in Early Symptomatic Knee Osteoarthritis: Results from the CHECK Cohort

Original Article

A Randomised Trial of a Weight Loss Intervention for Overweight and Obese People Diagnosed with Coronary Heart Disease and/or Type 2 Diabetes

Neu in den Fachgebieten Neurologie und Psychiatrie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Bildnachweise